Sort
166,118 grants matching “stem cells”
Decoding and targeting the PI3K-mTOR signaling network in cancer
$877,757Brendan D. Manning · Harvard School Of Public Health · R35 · FY2019 · CA
Molecular and Cellular Biology Training
$877,730Benjamin S. Glick · University Of Chicago · T32 · FY2021 · GM
Stem Cell and Transplantation Biology
$877,701Derek L Stirewalt · Fred Hutchinson Cancer Center · U54 · FY2025 · DK
Discovery and optimization of ApoE4 correctors for the treatment of Alzheimer's Disease
$877,636Michael Jackson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · AG
Epigenome Interactions in Complex Neurogenetic Disorders
$877,497Margaret Elizabeth Ross · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · NS
CELLULAR BASIS OF HYPERSENSITIVITY DISEASES IN HUMANS
$877,439Brigham And Women'S Hospital · P01 · FY2002 · AI
Regulation mechanism and functional genomics of LINE1 RNA in TDP-43 linked neurodegeneration
$877,436Shuying Sun · Johns Hopkins University · R01 · FY2022 · AG
A MULTICELLULAR, HUMAN PLURIPOTENT STEM CELL-DERIVED PLATFORM TO STUDY NEUROINFLAMMATION IN AMYOTROPHIC LATERAL SCLEROSIS
$877,426Sloan-Kettering Institute For Cancer Research · · FY2021 · Defense Health Agency
GrowthDifferentiation Factors in Organogenesis
$877,374Alan Perantoni · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Recycling: An Alternative Method for Rapid Gap Junction Plaque Assembly
$877,274Sandra A Murray · University Of Pittsburgh · · FY2020 · BIO
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
$877,246Scott Allen Noggle · New York Stem Cell Foundation · R01 · FY2021 · AG
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
$877,246Valentina Fossati · New York Stem Cell Foundation · R01 · FY2022 · AG
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
$877,246Scott Allen Noggle · New York Stem Cell Foundation · R01 · FY2020 · AG
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
$877,246Scott Allen Noggle · New York Stem Cell Foundation · R01 · FY2019 · AG
Compound repositioning for Alzheimer's Disease using knowledge graphs, insurance claims data, and gene expression complementarity
$877,205Andrew I Su · Scripps Research Institute, The · R01 · FY2024 · AG
Human Neural Stem Cells in Primate Parkinson's Model
$877,159Yale University · R01 · FY2004 · NS
KSHV Infection And Persistence
$877,104Kenneth M Kaye · Brigham And Women'S Hospital · R01 · FY2025 · AI
Development of 211Astatine-Conjugated Anti-CD45 Antibody-Based Conditioning for Hematopoietic Stem Cell Gene Therapy and Editing
$877,086Roland Bruno Walter · Fred Hutchinson Cancer Center · R01 · FY2021 · HL
Modeling neurofibromatosis-1 disease heterogeneity to optimize risk assessment and treatment
$877,001David H. Gutmann · Washington University · R35 · FY2025 · NS
PATHOGENESIS AND PREVENTION OF IDDM
$876,956Stanford University · P01 · FY2001 · DK
Basic Research Support for the CCR
$876,849Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Mechanisms of Cellular Transformation by HTLV-1
$876,847Kuan-Teh Jeang · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
CEACAM-1a regulates graft-versus-host-disease after allogeneic HSCT
$876,767Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · R01 · FY2010 · HL
Neural Crest Development and Disease
$876,628Laura Kerosuo · National Institute Of Dental & Craniofacial Research · ZIA · FY2019 · DE
A community resource for germline and somatic genetic disease modeling in zebrafish
$876,458Calum A. Macrae · Brigham And Women'S Hospital · R24 · FY2025 · OD